摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N1,N3-dibutylisophthalamide | 15088-35-4

中文名称
——
中文别名
——
英文名称
N1,N3-dibutylisophthalamide
英文别名
isophthalic acid dibutylamide;N,N'-dibutyl-isophthalamide;Isophthalsaeure-bis-(monobutylamid);N,N'-Di-n-butylisophthalamid;N,N'-dibutylisophthalamide;1-N,3-N-dibutylbenzene-1,3-dicarboxamide
N<sup>1</sup>,N<sup>3</sup>-dibutylisophthalamide化学式
CAS
15088-35-4
化学式
C16H24N2O2
mdl
MFCD01213040
分子量
276.379
InChiKey
UEUJQJBBZXOQII-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 保留指数:
    2746

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    20
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N1,N3-dibutylisophthalamide盐酸硼烷四氢呋喃络合物 作用下, 生成 N,N'-Dibutyl-m-phenylen-dimethanamin-dihydrochlorid
    参考文献:
    名称:
    Aromatic analogs of arcaine inhibit MK-801 binding to the NMDA receptor
    摘要:
    Aromatic analogs of arcaine were shown to have inhibitory effects on the binding of the channel blocking drug [H-3]MK-801 to the NMDA receptor complex. The most potent compound of the series was an N,N'-bis(propyl)guanidinium which inhibited [H-3]MK-801 binding with an IC50 of 0.58 mu M and an IC50 of 12.17 mu M upon addition of 100 mu M spermidine. The increase in IC50 upon addition of spermidine suggests competitive antagonism between the inhibitor and spermidine at the arcaine-sensitive polyamine site of the NMDA receptor complex. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(98)00631-3
  • 作为产物:
    描述:
    间苯二甲酸草酰氯 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 生成 N1,N3-dibutylisophthalamide
    参考文献:
    名称:
    Aromatic analogs of arcaine inhibit MK-801 binding to the NMDA receptor
    摘要:
    Aromatic analogs of arcaine were shown to have inhibitory effects on the binding of the channel blocking drug [H-3]MK-801 to the NMDA receptor complex. The most potent compound of the series was an N,N'-bis(propyl)guanidinium which inhibited [H-3]MK-801 binding with an IC50 of 0.58 mu M and an IC50 of 12.17 mu M upon addition of 100 mu M spermidine. The increase in IC50 upon addition of spermidine suggests competitive antagonism between the inhibitor and spermidine at the arcaine-sensitive polyamine site of the NMDA receptor complex. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(98)00631-3
点击查看最新优质反应信息

文献信息

  • Synthesis and NMR Binding Studies towards Rational Design of a Series of Electron-Withdrawing Diamide Receptors/Organocatalysts
    作者:Michael Kinsella、Patrick G. Duggan、Jimmy Muldoon、Kevin S. Eccles、Simon E. Lawrence、Claire M. Lennon
    DOI:10.1002/ejoc.201001439
    日期:2011.2
    A related series of bisamides have been evaluated for rational correlation between anion complexation and organocatalysis: remarkable enhancement of hydrogen bonding to anions was observed along with significant increases in catalytic activity in the Baylis–Hillman reaction. In addition, X-ray crystallography showed a large degree of pre-organisation was observed in one receptor by incorporation of
    已经评估了一系列相关双酰胺的阴离子络合和有机催化之间的合理相关性:观察到氢键与阴离子的显着增强以及 Baylis-Hillman 反应中催化活性的显着增加。此外,X 射线晶体学表明,通过结合双(三氟甲基)苯胺基团和硫代酰胺官能团,在一个受体中观察到了很大程度的预组织。该系列中的新型双功能酰胺/N-酰基磺酰胺具有最佳催化性能。
  • Aromatic isophthalamides aggregate in lipid bilayers: evidence for a cooperative transport mechanism
    作者:Stuart N. Berry、Nathalie Busschaert、Charlotte L. Frankling、Dale Salter、Philip A. Gale
    DOI:10.1039/c4ob02631d
    日期:——
    The synthesis and anion transport properties of a series of transmembrane anion transporters based on an isophthalamide scaffold with phenyl, naphthyl or anthracenyl central rings are reported. Anion transport studies using POPC vesicles, showed that the compounds have Hill coefficients >1. This is indicative of higher order complex formation, evidence that leads us to suggest that the compounds are
    报道了一系列基于间苯二甲酰胺骨架并带有苯基,萘基或蒽基中心环的跨膜阴离子转运蛋白的合成和阴离子转运特性。使用POPC囊泡的阴离子迁移研究表明,该化合物的Hill系数> 1。这表明高阶复合物的形成,证据使我们提出这些化合物并非仅作为移动载体发挥作用,而是正在观察到一种协同转运机制。使用荧光光谱法显示化合物在磷脂双层中聚集,这提供了这些化合物充当自组装阴离子传导聚集体的证据。
  • Platelet Aggregation Inhibiting and Anticoagulant Effects of Oligoamines, XXII: Bisoxazol-, Bisimidazol-, Bisthiazol- and Oligo-1,2,4-thiadiazolimines
    作者:Klaus Rehse、Antje Martens
    DOI:10.1002/ardp.19933260706
    日期:——
    for their antiplatelet and anticoagulant activities. The most potent compound was the tris‐thiadiazole derivative 18m which inhibited the aggregation of platelets induced by collagen at a concentration of 10 μmol/L by 50 percent (Born‐test). No anticoagulant effects (Quick‐test) were observed up to 400 μmol/L. In the thiazolamine series combined antiplatelet and anticoagulant activities were seen.
    一个介离子4,4'-丙烯-双-恶唑-5-亚胺(5),两个2,2'-间-亚苯基-双-咪唑-4-亚胺(9a,b),五个4,4'-苯-双-(和三)-噻唑-2-胺(13a、b、14a-c)和 14 3,3'-苯-双-(和三)-1,2,4-噻二唑亚胺(18a-o)合成并测定了它们的抗血小板和抗凝活性。最有效的化合物是三噻二唑衍生物 18m,它在 10 μmol/L 的浓度下抑制了 50% 的胶原蛋白诱导的血小板聚集(Born 试验)。在高达 400 μmol/L 时未观察到抗凝作用(快速测试)。在噻唑胺系列中可以看到抗血小板和抗凝活性的结合。
  • Stehlicek, Jaroslav; Sebenda, Jan, Collection of Czechoslovak Chemical Communications, 1980, vol. 45, # 9, p. 2524 - 2531
    作者:Stehlicek, Jaroslav、Sebenda, Jan
    DOI:——
    日期:——
  • INK COMPOSITION AND METHOD OF JETTING INK
    申请人:Morimitsu Kentaro
    公开号:US20140285594A1
    公开(公告)日:2014-09-25
    A phase change ink composition is disclosed. The composition comprises a crystalline component including a diamide compound with an aromatic ring core; an amorphous component; and optionally a colorant. Methods of printing the phase change ink composition are also disclosed.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐